{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:48:04Z","timestamp":1790340484227,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.jneuroim.2009.01.021","type":"journal-article","created":{"date-parts":[[2009,2,22]],"date-time":"2009-02-22T01:30:51Z","timestamp":1235266251000},"page":"87-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Suppression of experimental autoimmune myasthenia gravis by inhibiting the signaling between IFN-\u03b3 inducible protein 10 (IP-10) and its receptor CXCR3"],"prefix":"10.1016","volume":"209","author":[{"given":"Tali","family":"Feferman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revital","family":"Aricha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren","family":"Mizrachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erez","family":"Geron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronen","family":"Alon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam. C.","family":"Souroujon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2009.01.021_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0019-2791(77)90291-9","article-title":"Immunochemical studies on acetylcholine receptor fraction from Torpedo californica","volume":"14","author":"Aharonov","year":"1977","journal-title":"Immunochemistry"},{"key":"10.1016\/j.jneuroim.2009.01.021_bib2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1096\/fj.05-4909fje","article-title":"Overexpression of phosphodiesterases in experimental autoimmune myasthenia gravis: suppression of disease by a phosphodiesterase inhibitor","volume":"20","author":"Aricha","year":"2006","journal-title":"Faseb J."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1067\/msy.2003.213","article-title":"Genetic deletion of chemokine receptor CXCR3 or antibody blockade of its ligand IP-10 modulates posttransplantation graft-site lymphocytic infiltrates and prolongs functional graft survival in pancreatic islet allograft recipients","volume":"134","author":"Baker","year":"2003","journal-title":"Surgery"},{"key":"10.1016\/j.jneuroim.2009.01.021_bib4","doi-asserted-by":"crossref","first-page":"6873","DOI":"10.1073\/pnas.96.12.6873","article-title":"CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions","volume":"96","author":"Balashov","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib5","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jaci.2006.02.039","article-title":"The role of the mast cell in the pathophysiology of asthma","volume":"117","author":"Bradding","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib6","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.4049\/jimmunol.162.5.2511","article-title":"Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes","volume":"162","author":"Bradley","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jaut.2006.11.001","article-title":"In vivo administration of plasmid DNA encoding recombinant immunotoxin DT390-IP-10 attenuates experimental autoimmune encephalomyelitis","volume":"28","author":"Chen","year":"2007","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbmt.2006.12.293","article-title":"A small molecular weight antagonist of CXCR3 reduces the severity of experimental idiopathic pneumonia syndrome and improves survival following allogeneic stem cell transplantation","volume":"13","author":"Deurloo","year":"2007","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib9","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.tips.2006.08.001","article-title":"Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease","volume":"27","author":"Donnelly","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0022-1759(74)90109-4","article-title":"Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll\u2013Hypaque","volume":"5","author":"English","year":"1974","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jneuroim.2009.01.021_bib11","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.4049\/jimmunol.174.9.5324","article-title":"Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis","volume":"174","author":"Feferman","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib12","doi-asserted-by":"crossref","first-page":"7617","DOI":"10.4049\/jimmunol.166.12.7617","article-title":"CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis","volume":"166","author":"Fife","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib13","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S","article-title":"Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation","volume":"194","author":"Flier","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2990.2001.00312.x","article-title":"CXCR3 expression in human central nervous system diseases","volume":"27","author":"Goldberg","year":"2001","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib15","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1084\/jem.168.3.941","article-title":"Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques","volume":"168","author":"Gottlieb","year":"1988","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib16","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1084\/jem.192.10.1515","article-title":"Requirement of the chemokine receptor CXCR3 for acute allograft rejection","volume":"192","author":"Hancock","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib17","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/art.21745","article-title":"Antagonist of interferon-inducible protein 10\/CXCL10 ameliorates the progression of autoimmune sialadenitis in MRL\/lpr mice","volume":"54","author":"Hasegawa","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib18","doi-asserted-by":"crossref","first-page":"R1001","DOI":"10.1186\/ar1776","article-title":"Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"7","author":"Henneken","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib19","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1172\/JCI8121","article-title":"Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment","volume":"104","author":"Im","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-5728(00)00395-7","article-title":"Mechanism of nasal tolerance induced by a recombinant fragment of acetylcholine receptor for treatment of experimental myasthenia gravis","volume":"111","author":"Im","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib21","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1084\/jem.194.9.1375","article-title":"Tumor necrosis factor-dependent segmental control of MIG expression by high endothelial venules in inflamed lymph nodes regulates monocyte recruitment","volume":"194","author":"Janatpour","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib22","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1016\/j.bmcl.2007.03.106","article-title":"Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3","volume":"17","author":"Johnson","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib23","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.4049\/jimmunol.171.6.2960","article-title":"Differential chemokine responses and homing patterns of murine TCR alpha beta NKT cell subsets","volume":"171","author":"Johnston","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib24","doi-asserted-by":"crossref","first-page":"G345","DOI":"10.1152\/ajpgi.00002.2006","article-title":"Role of IP-10\/CXCL10 in the progression of pancreatitis-like injury in mice after murine retroviral infection","volume":"291","author":"Kawauchi","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib25","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4049\/jimmunol.172.1.550","article-title":"IFN-inducible protein 10\/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis","volume":"172","author":"Klein","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib26","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.4049\/jimmunol.146.7.2245","article-title":"Recombinant human acetylcholine receptor alpha-subunit induces chronic experimental autoimmune myasthenia gravis","volume":"146","author":"Lennon","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0070-2153(05)68006-4","article-title":"Chemokine receptor CXCR3: an unexpected enigma","volume":"68","author":"Liu","year":"2005","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib28","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.4049\/jimmunol.176.7.4399","article-title":"Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3\u2212\/\u2212 mice with experimental autoimmune encephalomyelitis","volume":"176","author":"Liu","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib29","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1084\/jem.184.3.963","article-title":"Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes","volume":"184","author":"Loetscher","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib30","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199802123380706","article-title":"Chemokines\u2013chemotactic cytokines that mediate inflammation","volume":"338","author":"Luster","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib31","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1172\/JCI6993","article-title":"Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells","volume":"104","author":"Mach","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jneuroim.2005.08.022","article-title":"Characterization of relapsing autoimmune encephalomyelitis and its treatment with decoy chemokine receptor genes","volume":"170","author":"Matsumo","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib33","series-title":"Discovery and Development of the CXCR3 Antagonist T487 as Therapy for Th1 Mediated Disorders. Presented at the 29th National Medicinal Chemistry Symposium (Madison, Wisconsin)","author":"Medina","year":"2004"},{"key":"10.1016\/j.jneuroim.2009.01.021_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2008.05.023","article-title":"Suppression of Experimental autoimmune myasthenia gravis by combination therapy: pentoxifylline as a steroid-sparing agent","author":"Menon","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib35","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.4049\/jimmunol.179.12.8463","article-title":"Blockade of chemokine receptor CXCR3 inhibits T cell recruitment to inflamed joints and decreases the severity of adjuvant arthritis","volume":"179","author":"Mohan","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib36","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1006\/cyto.2000.0757","article-title":"Serum levels of ifn-inducible PROTEIN-10 relating to the activity of systemic lupus erythematosus","volume":"12","author":"Narumi","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.jneuroim.2009.01.021_bib37","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/1521-4141(200206)32:6<1784::AID-IMMU1784>3.0.CO;2-R","article-title":"Neutralization of IFN-inducible protein 10\/CXCL10 exacerbates experimental autoimmune encephalomyelitis","volume":"32","author":"Narumi","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib38","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1359-6101(97)00015-4","article-title":"The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily","volume":"8","author":"Neville","year":"1997","journal-title":"Cytokine Growth Factor. Rev."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/clim.2000.4957","article-title":"CXCR3 and CCR5 ligands in rheumatoid arthritis synovium","volume":"98","author":"Patel","year":"2001","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib40","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1182\/blood.V95.11.3289","article-title":"The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial\/stromal migration and engraftment of NOD\/SCID mice","volume":"95","author":"Peled","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2009.01.021_bib41","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI1422","article-title":"The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions","volume":"101","author":"Qin","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib42","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.4049\/jimmunol.169.5.2685","article-title":"Targeting the function of IFN-gamma-inducible protein 10 suppresses ongoing adjuvant arthritis","volume":"169","author":"Salomon","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib43","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1002\/1521-4141(200211)32:11<3197::AID-IMMU3197>3.0.CO;2-1","article-title":"Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival","volume":"32","author":"Sasaki","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib44","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0165-5728(02)00263-1","article-title":"Expression of chemokine receptor CXCR3 on cerebrospinal fluid T-cells is related to active MRI lesion appearance in patients with relapsing-remitting multiple sclerosis","volume":"131","author":"Sindern","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib45","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.4049\/jimmunol.171.3.1401","article-title":"Inhibition of IFN-gamma-inducible protein-10 abrogates colitis in IL-10\u2212\/\u2212 mice","volume":"171","author":"Singh","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib46","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1172\/JCI5150","article-title":"Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients","volume":"103","author":"Sorensen","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib47","article-title":"A small-molecule compound targeting CCR5 and CXCR3 prevents the development of asthma","author":"Suzaki","year":"2007","journal-title":"Eur. Respir. J"},{"key":"10.1016\/j.jneuroim.2009.01.021_bib48","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2249.2005.02850.x","article-title":"Accumulation of plasma cells expressing CXCR3 in the synovial sublining regions of early rheumatoid arthritis in association with production of Mig\/CXCL9 by synovial fibroblasts","volume":"141","author":"Tsubaki","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib49","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0002-9440(10)65128-0","article-title":"Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis","volume":"155","author":"Uguccioni","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib50","article-title":"CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor deficient mice","author":"van Wanrooij","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1016\/j.jneuroim.2009.01.021_bib51","doi-asserted-by":"crossref","first-page":"7701","DOI":"10.1158\/0008-5472.CAN-06-0709","article-title":"Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer","volume":"66","author":"Walser","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib52","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0022-3565(25)20148-3","article-title":"Chronic intrathecal infusion of phosphorothioate or phosphodiester antisense oligonucleotides against cytokine responsive gene-2\/IP-10 in experimental allergic encephalomyelitis of lewis rat","volume":"278","author":"Wojcik","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jneuroim.2009.01.021_bib53","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.4049\/jimmunol.175.3.2018","article-title":"IL-1 receptor antagonist-mediated therapeutic effect in murine myasthenia gravis is associated with suppressed serum proinflammatory cytokines, C3, and anti-acetylcholine receptor IgG1","volume":"175","author":"Yang","year":"2005","journal-title":"J. Immunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572809000265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572809000265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:11:43Z","timestamp":1759047103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572809000265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":53,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0165572809000265"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2009.01.021","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppression of experimental autoimmune myasthenia gravis by inhibiting the signaling between IFN-\u03b3 inducible protein 10 (IP-10) and its receptor CXCR3","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2009.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}